Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

P3.16-02 Phase III Study of Canakinumab (ACZ885) As Adjuvant Therapy in Patients with Surgically Resected NSCLC

E. Garon,A. Ardizzoni,F. Barlesi,B. C. Cho,P. De Marchi,Y. Goto,S. Lu,L. Paz-Ares,D. Spigel,M. Thomas,P. Cazorla Arratia, J. Baum,Y. Lau, C. Zheng,J. C. Yang

Journal of thoracic oncology（2018）

Cited 0|Views41
No score
Key words
Canakinumab,ADJUVANT,NSCLC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined